| 摘要 |
<p>Delivery of Latrunculin A or B locally, particularly from an intraluminal prothesis such as a coronary stent, directly from the surface of the prothesis or from pores, micropores, or perforations in the stent body, mixed or bound to a polymer coating applied on the endoluminal prothesis, or mixed or bound toa glue applied to the endoluminal prothesis, to inhibit neointimal tissue proliferation and ingrowth of tissue, thereby facilitating the performance of the prothesis in inhibiting restenosis.</p> |
